Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × TIC10 compound × 90 days × Clear all

Phase

Phase 3 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Diffuse Intrinsic Pontine Glioma 1

Interventions

pembrolizumab 111 Carboplatin 108 Cisplatin 101 Paclitaxel 84 Gemcitabine 78 Specimen Handling 72 Magnetic Resonance Spectroscopy 69 Docetaxel 59 Dexamethasone 53 Capecitabine 53 Pemetrexed 52 Cyclophosphamide 52 Oxaliplatin 51 Radiotherapy 50 Doxorubicin 46 Bevacizumab 44 Rituximab 42 durvalumab 41 Radiation 41 Fluorouracil 40 Lenalidomide 37 Leucovorin 36 Vincristine 35 atezolizumab 32 Etoposide 28 130-nm albumin-bound paclitaxel 28 Letrozole 27 Prednisone 26 Nivolumab 26 Irinotecan 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05476939 2026-02-05

BIOMEDE 2

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Recruiting

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡